CS logo
small CS logo
Krankenhaus Waldfriede e. V.

Berlin, Germany
General hospital in Berlin
Argentinische Allee 40, 14163 Berlin

About Krankenhaus Waldfriede e. V.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Takeda
6
Celgene
5
Hoffmann-La Roche
4
Eli Lilly and Company
3
Pfizer
3
Waldfriede Hospital
3
Arena Pharmaceuticals
2
Janssen Research & Development, LLC
2
Charite University, Berlin, Germany
1
Cook Group Incorporated
1
TxCell
1
Total Rows: 11

Clinical Trials at Krankenhaus Waldfriede e. V.


During the past decade, Krankenhaus Waldfriede e. V. conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 12 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years55331188335500110000000033221166Started TrialsCompleted Trails201520162017201820192020202120220246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Clinical Trial Comparing Surgisis AFP to Advancement Flap for the Repair of Anal Fistulas
2008-06-01
2013-04-01
Completed
86
Telemedical Interventional Management in Heart Failure II
2013-08-08
2018-05-17
Completed
1,571
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
2014-12-24
2020-06-23
Completed
397
Study Evaluating Ovasave, an Autologous Cell Therapy, in Patients With Active Crohn's Disease
2014-12-01
2016-11-01
Terminated
32
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
2015-06-29
2019-01-18
Completed
771

Rows per page:

1–31 of 31

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Krankenhaus Waldfriede e. V." #1 sponsor was "Takeda" with 6 trials, followed by "Celgene" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Waldfriede e. V." #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Cook Biotech Incorporated" with 1 trials as a collaborator, "Cook Ireland, Ltd." with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsTakeda: 6Takeda: 6Celgene: 5Celgene: 5Hoffmann-La Roche: 4Hoffmann-La Roche: 4Eli Lilly and Company: 3Eli Lilly and Company: 3Pfizer: 3Pfizer: 3Waldfriede Hospital: 3Waldfriede Hospital: 3Arena Pharmaceuticals: 2Arena Pharmaceuticals: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Charite University,Berlin, Germany: 1Charite University,Berlin, Germany: 1Cook Group Incorporated: 1Cook Group Incorporated: 1

Created with Highcharts 11.1.0Top CollaboratorsTakeda DevelopmentCenter Americas, Inc.:2Takeda DevelopmentCenter Americas, Inc.:2Arena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1Cook Biotech Incorporated: 1Cook Biotech Incorporated: 1Cook Ireland, Ltd.: 1Cook Ireland, Ltd.: 1German FederalMinistry of Educationand Research: 1German FederalMinistry of Educationand Research: 1University of Leipzig: 1University of Leipzig: 1

Clinical Trials Conditions at Krankenhaus Waldfriede e. V.


According to Clinical.Site data, the most researched conditions in "Krankenhaus Waldfriede e. V." are "Crohn Disease" (9 trials), "Ulcerative Colitis" (9 trials), "Crohn's Disease" (6 trials), "Colitis, Ulcerative" (3 trials) and "Anal Fistula" (1 trials). Many other conditions were trialed in "Krankenhaus Waldfriede e. V." in a lesser frequency.

Clinical Trials Intervention Types at Krankenhaus Waldfriede e. V.


Most popular intervention types in "Krankenhaus Waldfriede e. V." are "Drug" (25 trials), "Other" (5 trials), "Device" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Etrolizumab" (4 trials), "Etrasimod" (3 trials), "Ozanimod" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Krankenhaus Waldfriede e. V.


The vast majority of trials in "Krankenhaus Waldfriede e. V." are 31 trials for "All" genders.

Clinical Trials Status at Krankenhaus Waldfriede e. V.


Currently, there are NaN active trials in "Krankenhaus Waldfriede e. V.". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Krankenhaus Waldfriede e. V., undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Waldfriede e. V., 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 22Phase 3: 22Phase 2: 5Phase 2: 5Not Applicable: 2Not Applicable: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 11Recruiting: 11Completed: 10Completed: 10Active, not recruiting: 6Active, not recruiting: 6Terminated: 4Terminated: 4